Navigation Links
FDA Panel Weighs OK of 'Female Viagra'
Date:6/18/2010

Recent research has shown increase in sexual satisfaction, if not libido

FRIDAY, June 18 (HealthDay News) -- A U.S. Food and Drug Administration advisory panel on Friday was considering whether to approve a drug dubbed the "female Viagra" for premenopausal women with a diminished sex drive.

Called flibanserin, the drug is related to the antidepressant family and affects serotonin and other chemicals in the brain. Drug maker Boehringer Ingelheim has been seeking FDA approval of the drug.

While the agency isn't compelled to follow the recommendations of its advisory panels, it typically does so.

Earlier this week, the FDA released a review of two studies that found the drug didn't have much impact on a woman's libido but did seem to slightly boost sexual satisfaction, according to published reports.

Side effects seen with use of the drug included depression, fainting and dizziness, the FDA said.

The drug, with the proposed brand name Girosa, is designed to be taken in 100-milligram pills once a day at bedtime, according to the FDA.

Since the extraordinary success of Viagra for men, which hit the market a decade ago, pharmaceutical companies have repeatedly tried to find a comparable drug treatment for women. But none of those treatments has resulted in a significant benefit.

More information

To learn more about women's sexual health, visit the International Society for the Study of Women's Sexual Health.



-- HealthDay staff



SOURCES: U.S. Food and Drug Administration Web site


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. NFL Brain Injury Panel Raises Awareness of Potential Long-Term Consequences from Traumatic Brain Injuries
2. Panel calls for reducing colorectal cancer deaths by striking down barriers to screening
3. Federal Panel Urges Obesity Screening for Kids Ages 6 and Up
4. Scientific panel evaluates soy infant formula safety
5. Baxa to Sponsor ASHP Midday Symposium: Creating a Culture of Safety in Pharmacy, A Panel Discussion on Lessons Learned
6. PolitiFact Names 'Death Panels' Claim the Lie of the Year
7. Expert Panel Reaches Consensus on Our Ability to Improve Cognitive Health
8. Panel Intelligence Returns to MedPanel Name
9. Panel asks dairy avoiders: Are you getting enough?
10. Avoiding Dairy Due to Lactose Intolerance is Unnecessary in Most Cases and May Pose Diet and Health Risks, Concludes National Institutes of Health Consensus Development Conference Panel
11. All Global Launches Physician Panels in Russia and Poland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... , ... The IoT (Internet of Things) is revolutionizing the way the world ... businesses and individual consumers alike. Laboratories can maximize their profit margin by increasing ... $4 trillion to $11 trillion dollars by the year 2025. McKinsey expects the IoT ...
(Date:3/23/2017)... Atlanta, GA (PRWEB) , ... March 23, 2017 ... ... announced the release of SmartBen NOW, an innovative mobile app and centralized benefits ... gather and present critical information securely from multiple locations. For the first time, ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... businesses of the greater Fort Collins area, has unveiled a collaboration with nonprofit ... involvement program. Donations to this worthy cause may now be made at ...
(Date:3/23/2017)... ... March 23, 2017 , ... ChenMed, ... announced rapid completion of the strategic executive team expansion needed to further optimize ... the ChenMed executive team,” says Christopher Chen, MD, ChenMed Chief Executive Officer. ...
(Date:3/23/2017)... ... March 23, 2017 , ... Inflow IQ & Inflownomics of Raleigh, ... build on a solid foundation. As experts in dangerous situations the Inflow IQ ... coming soon. Inflownomics deliver ripe, fresh, clean & refreshing knowledge systems that enhance life. ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... and VANCOUVER, British Columbia , ... SPHS ) (the "Company" or "Sophiris"), a clinical ... of urological diseases, today announced that data from its ... drug as a focal treatment for localized prostate cancer, ... 2017 at the 32 nd Annual European Association ...
(Date:3/23/2017)... 2017  Ethicon* today announced the completion of ... held medical device company that manufactures and markets ... treatment of Gastroesophageal Reflux Disease (GERD). This acquisition ... portfolio of minimally invasive options for patients suffering ... of the transaction have not been disclosed. ...
(Date:3/23/2017)... , March 23, 2017  Additive Orthopaedics, ... announced that it has kicked off a multi-centered ... 3D printed bone segments. According to ... unique variable honeycomb lattice structures have already shown ... compared to current allograft wedges from which we ...
Breaking Medicine Technology: